
The global Angiogenesis Assay market size was valued at US$ 18 million in 2023. With growing demand in downstream market, the Angiogenesis Assay is forecast to a readjusted size of US$ 30 million by 2030 with a CAGR of 8.1% during review period.
The research report highlights the growth potential of the global Angiogenesis Assay market. Angiogenesis Assay are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Angiogenesis Assay. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Angiogenesis Assay market.
Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.
Key Features:
The report on Angiogenesis Assay market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Angiogenesis Assay market. It may include historical data, market segmentation by Type (e.g., In Vitro Assay Kit, In Vivo Assay Kit), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Angiogenesis Assay market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Angiogenesis Assay market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Angiogenesis Assay industry. This include advancements in Angiogenesis Assay technology, Angiogenesis Assay new entrants, Angiogenesis Assay new investment, and other innovations that are shaping the future of Angiogenesis Assay.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Angiogenesis Assay market. It includes factors influencing customer ' purchasing decisions, preferences for Angiogenesis Assay product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Angiogenesis Assay market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Angiogenesis Assay market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Angiogenesis Assay market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Angiogenesis Assay industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Angiogenesis Assay market.
Market Segmentation:
Angiogenesis Assay market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
In Vitro Assay Kit
In Vivo Assay Kit
Segmentation by application
Academic Institution
Biotech Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Angiogenesis Assay Market Size 2019-2030
2.1.2 Angiogenesis Assay Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Angiogenesis Assay Segment by Type
2.2.1 In Vitro Assay Kit
2.2.2 In Vivo Assay Kit
2.3 Angiogenesis Assay Market Size by Type
2.3.1 Angiogenesis Assay Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Angiogenesis Assay Market Size Market Share by Type (2019-2024)
2.4 Angiogenesis Assay Segment by Application
2.4.1 Academic Institution
2.4.2 Biotech Companies
2.5 Angiogenesis Assay Market Size by Application
2.5.1 Angiogenesis Assay Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Angiogenesis Assay Market Size Market Share by Application (2019-2024)
3 Angiogenesis Assay Market Size by Player
3.1 Angiogenesis Assay Market Size Market Share by Players
3.1.1 Global Angiogenesis Assay Revenue by Players (2019-2024)
3.1.2 Global Angiogenesis Assay Revenue Market Share by Players (2019-2024)
3.2 Global Angiogenesis Assay Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Angiogenesis Assay by Regions
4.1 Angiogenesis Assay Market Size by Regions (2019-2024)
4.2 Americas Angiogenesis Assay Market Size Growth (2019-2024)
4.3 APAC Angiogenesis Assay Market Size Growth (2019-2024)
4.4 Europe Angiogenesis Assay Market Size Growth (2019-2024)
4.5 Middle East & Africa Angiogenesis Assay Market Size Growth (2019-2024)
5 Americas
5.1 Americas Angiogenesis Assay Market Size by Country (2019-2024)
5.2 Americas Angiogenesis Assay Market Size by Type (2019-2024)
5.3 Americas Angiogenesis Assay Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiogenesis Assay Market Size by Region (2019-2024)
6.2 APAC Angiogenesis Assay Market Size by Type (2019-2024)
6.3 APAC Angiogenesis Assay Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Angiogenesis Assay by Country (2019-2024)
7.2 Europe Angiogenesis Assay Market Size by Type (2019-2024)
7.3 Europe Angiogenesis Assay Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Angiogenesis Assay by Region (2019-2024)
8.2 Middle East & Africa Angiogenesis Assay Market Size by Type (2019-2024)
8.3 Middle East & Africa Angiogenesis Assay Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Angiogenesis Assay Market Forecast
10.1 Global Angiogenesis Assay Forecast by Regions (2025-2030)
10.1.1 Global Angiogenesis Assay Forecast by Regions (2025-2030)
10.1.2 Americas Angiogenesis Assay Forecast
10.1.3 APAC Angiogenesis Assay Forecast
10.1.4 Europe Angiogenesis Assay Forecast
10.1.5 Middle East & Africa Angiogenesis Assay Forecast
10.2 Americas Angiogenesis Assay Forecast by Country (2025-2030)
10.2.1 United States Angiogenesis Assay Market Forecast
10.2.2 Canada Angiogenesis Assay Market Forecast
10.2.3 Mexico Angiogenesis Assay Market Forecast
10.2.4 Brazil Angiogenesis Assay Market Forecast
10.3 APAC Angiogenesis Assay Forecast by Region (2025-2030)
10.3.1 China Angiogenesis Assay Market Forecast
10.3.2 Japan Angiogenesis Assay Market Forecast
10.3.3 Korea Angiogenesis Assay Market Forecast
10.3.4 Southeast Asia Angiogenesis Assay Market Forecast
10.3.5 India Angiogenesis Assay Market Forecast
10.3.6 Australia Angiogenesis Assay Market Forecast
10.4 Europe Angiogenesis Assay Forecast by Country (2025-2030)
10.4.1 Germany Angiogenesis Assay Market Forecast
10.4.2 France Angiogenesis Assay Market Forecast
10.4.3 UK Angiogenesis Assay Market Forecast
10.4.4 Italy Angiogenesis Assay Market Forecast
10.4.5 Russia Angiogenesis Assay Market Forecast
10.5 Middle East & Africa Angiogenesis Assay Forecast by Region (2025-2030)
10.5.1 Egypt Angiogenesis Assay Market Forecast
10.5.2 South Africa Angiogenesis Assay Market Forecast
10.5.3 Israel Angiogenesis Assay Market Forecast
10.5.4 Turkey Angiogenesis Assay Market Forecast
10.5.5 GCC Countries Angiogenesis Assay Market Forecast
10.6 Global Angiogenesis Assay Forecast by Type (2025-2030)
10.7 Global Angiogenesis Assay Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abcam
11.1.1 Abcam Company Information
11.1.2 Abcam Angiogenesis Assay Product Offered
11.1.3 Abcam Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abcam Main Business Overview
11.1.5 Abcam Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Angiogenesis Assay Product Offered
11.2.3 Bio-Techne Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Angiogenesis Assay Product Offered
11.3.3 Thermo Fisher Scientific Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Cell Biolabs, Inc.
11.4.1 Cell Biolabs, Inc. Company Information
11.4.2 Cell Biolabs, Inc. Angiogenesis Assay Product Offered
11.4.3 Cell Biolabs, Inc. Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cell Biolabs, Inc. Main Business Overview
11.4.5 Cell Biolabs, Inc. Latest Developments
11.5 BioVision, Inc
11.5.1 BioVision, Inc Company Information
11.5.2 BioVision, Inc Angiogenesis Assay Product Offered
11.5.3 BioVision, Inc Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BioVision, Inc Main Business Overview
11.5.5 BioVision, Inc Latest Developments
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Information
11.6.2 PromoCell GmbH Angiogenesis Assay Product Offered
11.6.3 PromoCell GmbH Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 PromoCell GmbH Main Business Overview
11.6.5 PromoCell GmbH Latest Developments
11.7 Merck KGaA
11.7.1 Merck KGaA Company Information
11.7.2 Merck KGaA Angiogenesis Assay Product Offered
11.7.3 Merck KGaA Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Merck KGaA Main Business Overview
11.7.5 Merck KGaA Latest Developments
11.8 Kollodis BioSciences
11.8.1 Kollodis BioSciences Company Information
11.8.2 Kollodis BioSciences Angiogenesis Assay Product Offered
11.8.3 Kollodis BioSciences Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kollodis BioSciences Main Business Overview
11.8.5 Kollodis BioSciences Latest Developments
11.9 Sartorius (Essen BioScience)
11.9.1 Sartorius (Essen BioScience) Company Information
11.9.2 Sartorius (Essen BioScience) Angiogenesis Assay Product Offered
11.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sartorius (Essen BioScience) Main Business Overview
11.9.5 Sartorius (Essen BioScience) Latest Developments
11.10 Creative Bioarray
11.10.1 Creative Bioarray Company Information
11.10.2 Creative Bioarray Angiogenesis Assay Product Offered
11.10.3 Creative Bioarray Angiogenesis Assay Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Creative Bioarray Main Business Overview
11.10.5 Creative Bioarray Latest Developments
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
